A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia (Q40596325)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 September 2001
edit
Language Label Description Also known as
English
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia
scientific article published on 14 September 2001

    Statements

    A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia (English)
    Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit